Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| FEDERAL MOGU | FDML | 6.35% |
| NATUS MEDICA | BABY | 6.04% |
| RADIANT LOGI | RLGT | 5.85% |
| NEW ORIENTAL | EDU | 5.86% |
| SUMMER INFAN | SUMR | 5.36% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Westin Hotels & Resorts, one of the upscale brands of Starwood Hotels & Resorts Worldwide Inc. ( HOT - Analyst Report ) , recently reported over $125 million total revenue, since inception of a signature guest program in the national market known as Heavenly Bed. Westin became the first hotel company to conceptualize such a retail product in 2000.
Since the program commenced 12 years ago, the Westin brand has sold over 100,000 Heavenly Beds, 250,000 Heavenly Pillows and 173,000 White Tea by Westin scented products. Westin plans to celebrate the achievement by providing customers with attractive concessions.
Besides the national market, Westin’s retail sale program has also seen success in the international market. In Asia, Westin’s retail products are on a continuing growth trajectory with successful sales in 39 properties across the region.
Starwood has set a new trend in hotel designs with its Westin brand, which embodies a blend of modern design and peaceful ambience. The brand also offers signature retail services including the Heavenly Bed, SuperFoodsRX, WestinWorkout studio and others to customers seeking a unique experience.
In the second quarter of 2012, RevPAR growth at Westin was 7.5% in constant dollars, the third highest among Starwood hotel brands. Westin has strong global presence, with properties in North America, Europe, Latin America, India, Southeast Asia and China. As of now, Westin’s portfolio comprises of more than 186 hotels in over 40 countries and territories.
Starwood Hotels and Resorts, which competes with Marriott International Inc. ( MAR - Analyst Report ) , is the leading worldwide hospitality company. As of June 30, 2012, the company’s pipeline comprises of more than 365 hotels across its upscale brands, including Sheraton, Westin, St. Regis, The Luxury Collection and W, besides others.
In the recently completed second-quarter 2012, Starwood reported adjusted earnings from continuing operations of 70 cents, beating the Zacks Consensus Estimate by 8 cents. Moreover, the company increased its adjusted earnings guidance to the range of $2.49–$2.56 per share, from the earlier guidance range of $2.35–$2.46.
Currently, the Zacks Consensus Estimate for 2012 and 2013 adjusted earnings are pegged at $2.53 and $2.72 per share. We presently have a long-term 'Neutral' recommendation on the stock. Also, the company carries a Zacks #3 Rank, which translates into a short-term ‘Hold’ rating.
Read the full Analyst Report on HOT
Read the full Analyst Report on MAR